Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10124176 | 0.94 | SLC2A1 (0.33) | DHODHALDH1A1SMN1; SMN2 | |
| SCHEMBL10124122 | 0.93 | DHODH (0.34) | DHODHALDH1A1SMN1; SMN2MALT1 | |
| SCHEMBL10124116 | 0.93 | NPC1 (0.32) | DHODHALDH1A1SMN1; SMN2 | |
| SCHEMBL10124212 | 0.93 | SLC2A1 (0.33) | DHODHALDH1A1SMN1; SMN2HDAC6 | |
| SCHEMBL10124150 | 0.93 | SLC16A3 (0.33) | DHODHALDH1A1SMN1; SMN2 | |
| SCHEMBL19465207 | 0.93 | SLC2A1 (0.33) | DHODHALDH1A1SMN1; SMN2 | |
| SCHEMBL10151096 | 0.92 | DHODH (0.33) | DHODHALDH1A1SMN1; SMN2MALT1HDAC6 | |
| SCHEMBL685542 | 0.92 | DHODH (0.33) | DHODHALDH1A1SMN1; SMN2MALT1 | |
| SCHEMBL10072947 | 0.92 | DHODH (0.33) | DHODHALDH1A1SMN1; SMN2MALT1 | |
| SCHEMBL10124154 | 0.91 | CRHR1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9790202-B2 | Anthranilamide derivatives as pesticides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-10-17 | — | — | US | disclosed |
| US-9790202-B2 | Anthranilamide derivatives as pesticides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-10-17 | — | — | US | disclosed |
| US-20120010250-A1 | Anthranilamide derivatives as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-01-12 | — | — | US | disclosed |
| US-20120010250-A1 | Anthranilamide derivatives as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010250-A1 | Anthranilamide derivatives as pesticides | ANTXR2, NQO2, AADAC | DHODH 1510/4885ALDH1A1 1163/4885SMN1; SMN2 4194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.